HIPRAVIAR-CLON
HIPRAVIAR-CLON
Authorised
- Newcastle disease virus, strain CLON CL/79, Live
Product identification
Medicine name:
ХИПРАВИАР-КЛОН
HIPRAVIAR-CLON
Active substance:
- Newcastle disease virus, strain CLON CL/79, Live
Target species:
-
Poultry
Route of administration:
-
Oculonasal use
-
Oral use
Product details
Active substance and strength:
-
Newcastle disease virus, strain CLON CL/79, Live6.50/log 10 50% embryo infective dose1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for oral suspension
Withdrawal period by route of administration:
-
Oculonasal use
- Poultry
-
Oral use
- Poultry
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD06
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Hipra S.A.
Responsible authority:
- Bulgarian Food Safety Authority
Authorisation number:
- 0022-1958
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 22/03/2024
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 22/03/2024
How useful was this page?:
